Browsing by Author "Chitirala, Praneeth"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settingsStudying the biology of cytotoxic T lymphocytes in vivo with a fluorescent granzyme B-mTFP knock-in mouse(2020)
;Chitirala, Praneeth ;Chang, Hsin-Fang ;Martzloff, Paloma ;Harenberg, Christiane ;Ravichandran, Keerthana ;Abdulreda, Midhat H ;Berggren, Per-Olof ;Krause, Elmar ;Schirra, Claudia ;Leinders-Zufall, TreseRettig, JensUnderstanding T cell function in vivo is of key importance for basic and translational immunology alike. To study T cells in vivo, we developed a new knock-in mouse line, which expresses a fusion protein of granzyme B, a key component of cytotoxic granules involved in T cell-mediated target cell-killing, and monomeric teal fluorescent protein from the endogenous Gzmb locus. Homozygous knock-ins, which are viable and fertile, have cytotoxic T lymphocytes with endogeneously fluorescent cytotoxic granules but wild-type-like killing capacity. Expression of the fluorescent fusion protein allows quantitative analyses of cytotoxic granule maturation, transport and fusion in vitro with super-resolution imaging techniques, and two-photon microscopy in living knock-ins enables the visualization of tissue rejection through individual target cell-killing events in vivo. Thus, the new mouse line is an ideal tool to study cytotoxic T lymphocyte biology and to optimize personalized immunotherapy in cancer treatment. - Some of the metrics are blocked by yourconsent settingsTherapeutic Application of alpha-1-antitrypsin in COVID-19(2021)
;Ritzmann, Felix ;Chitirala, Praneeth ;Krüger, Nadine ;Hoffmann, Markus ;Zuo, Wei ;Lammert, Frank ;Smola, Sigrun ;Tov, Naveh ;Alagem, Noga ;Bals, Robertfor the AAT-in-COVID-19 study group